Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREMELIMUMAB-ACTL: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

33.3%
Female
66.7%
Male

Age Information

The average age of patients reporting adverse events with TREMELIMUMAB-ACTL is 67.3 years.

Geographic Distribution

The majority of adverse event reports for TREMELIMUMAB-ACTL originate from US.

Report Summary & Outcomes

39
Total Reports
39
As Primary/Secondary Suspect
13
Deaths Reported
10
Hospitalizations
3
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20221119. Most recent report: 20230627. View full timeline →

More About TREMELIMUMAB-ACTL

TREMELIMUMAB-ACTL Full Profile Reports by Year Drug Interactions